ARCHIVES

ODAC Votes 10-0 In Favor Of Avastin For Recurrent Glioblastoma Multiforme

This article is from The Cancer Letter archive.

Vol. 35 No. 13 | April 3, 2009

Download PDF Visit The Full Archive

Related Articles

Q&A: Data that Killed CYP2D6 Testing Contradict Fundamental Law of Nature

May 18, 2012

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

October 9, 2009

First NCAB “Road” Hearing In L.A.

September 18, 1987

DCPC Board Oks Concept For Three New Grant Programs, Three Contracts

May 22, 1987

In Brief: ACS Seeking Candidate for Holleb Replacement; NCI To Recruit AD For Biological Carcinogenesis

March 13, 1987

Six Comprehensive Center Asked By Candlelighters For Pediatric Cancer

March 24, 1978